• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Avive Solutions raises $22M for wirelessly connected AED technology

Avive Solutions raises $22M for wirelessly connected AED technology

March 16, 2022 By Sean Whooley

Avive Solutions LogoOut-of-hospital cardiac arrest (OHCA) treatment developer Avive Solutions announced today that it closed a $22 million Series A financing round.

San Francisco-based Avive develops an intelligent automated external defibrillator (AED) and connected response platform. The company will use the funding to advance its AED platform.

Avive’s offering integrates the Avive Connect AED — which awaits FDA approval — with its proprietary, data-driven emergency response software platform, all of which seamlessly connects with 911 emergency communications centers through a partnership with RapidSOS, according to a news release.

Update: The Avive Connect AED received FDA premarket approval in January 2023.

The platform offers incident data-sharing capabilities to providers with the aim of closing data gaps that often exist during cardiac arrest response. Emergency communications centers with access to RapidSOS can dispatch Avive Connect AEDs to the location of a cardiac arrest emergency by audibly alerting and displaying a map on the device to navigate bystanders to the location of the person in cardiac arrest.

Avive said it designed the system to reduce time to defibrillation and increase the likelihood of AEDs being used before emergency medical services arrive, which can potentially increase survival rates.

“Avive is changing the paradigm of response to cardiac arrest emergencies through our connected platform,” Avive Co-Founder and CEO Sameer Jafri said in the release. “By getting life-saving AED technology in the hands of bystanders who can provide immediate help when and where it’s needed, and facilitating closer collaboration with emergency responders and healthcare providers, we believe our vision for a more streamlined system of care can greatly improve the odds of survival.”

Questa Capital, Catalyst Health Ventures and repeat investor Laerdal Million Lives Fund led the Series A financing round. Questa Founder and Managing Partner Ryan Drant, along with Catalyst Managing Partner Darshana Zaveri, both joined Avive’s board in connection with the financing.

Filed Under: Big Data, Business/Financial News, Cardiovascular, Funding Roundup, Health Technology, Software / IT Tagged With: Avive Solutions

More recent news

  • Zenflow nets $52M, Cook Medical deal for in-office enlarged prostate implant
  • Abbott to update CardioMEMS to allow patients to track pulmonary artery pressure
  • Wandercraft acquires exoskeleton rival Ekso Bionics
  • GE HealthCare to buy Sofie Biosciences in $945M radiopharmaceutical play
  • Carlsmed names chief product and AI officer as it claims CMS reimbursements

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy